AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against <it>Plasmodium falciparum </it>merozoite surface protein 4 and 5
<p>Abstract</p> <p>Background</p> <p>Whilst a large number of malaria antigens are being tested as candidate malaria vaccines, a major barrier to the development of an effective vaccine is the lack of a suitable human adjuvant capable of inducing a strong and long lasti...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-02-01
|
| Series: | Malaria Journal |
| Online Access: | http://www.malariajournal.com/content/8/1/35 |